Stockreport

Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report

Alterity Therapeutics Limited - American Depositary Shares  (ATHE) 
PDF Highlights New analysis of ATH434-201 double blind trial strengthens efficacy signal at high dose levelPositive data from ATH434-202 open-label trial demonstrates simil [Read more]